Date |
Session |
Speaker |
Topic |
October 15th
|
Openning Lecture |
Wojciech Zareba |
Drug-Induce QT prolongation - talk |
|
|
Wojciech Zareba |
Drug-Induced QT prolongation - Manuscript |
|
Mechanisms |
Charles Antzelevitch |
Drug-Induced Spatial Dispersion of Repolarization |
|
Methods |
Paul Kligfield |
ECG Measurement of QT Interval |
|
Clinical Aspects |
Arthur Moss |
Long QT Syndrome as Paradigm for Drug-Induced QT Prolongation |
|
Drug Testing |
William Wheeler |
Drug-Induced Torsade de Pointes: Regulatory Evolution |
October 16th
|
Mechanisms |
Nabil El-Sherif |
Mechanism of Drug-Induced TdP |
|
Methods |
Ilan Goldenberg |
How to Measure QT |
|
Clinical Aspects |
James Daubert |
Managing the Safety of Drugs for Atrial Fibrillation |
|
Drug Testing |
Fabio Badilini |
QT Measurements On-screen Methods |
October 17th
|
Mechanisms |
Dan Roden |
Pharmacogenomics of Drug-Induced Conditions |
|
Methods |
Pentti Rautaharju |
Is QT Prolonged or Shortened? Normal Limits. |
|
Clinical Aspects |
Wojciech Zareba |
Antipsychotic Drugs and Risk of TdP |
|
Drug Testing |
Jean Philippe Couderc |
Beyond QT Prolongation in Drug Studies |
October 18th
|
Mechanisms |
Michael Sanguinetti |
hERG Channel Function in LQT2 and Drug Induced Conditions |
|
Methods |
Marek Malik |
Heart Rate Correction of the QT interval |
|
Clinical Aspects |
Richard Kovacs |
Antibiotics and Acquired Long QT Syndrome: Advice for the Prescriber. |
|
Drug Testing |
Borje Darpo |
What QT prolongation is of concern? |
October 19th
|
Mechanisms |
Terry Campbell |
Predicting Drug-HERG Interactions |
|
Methods |
Emanuela Locati |
QT Interval Dynamics |
|
Clinical Aspects |
Luiz Belardinelli |
Not All QT-prolonging Drugs are Torsadogenics |
|
Drug Testing |
Dirhaj Narula |
ECG Core Laboratory Approach to Drug testing |
October 20th
|
Mechanisms |
Silvia Priori |
Ion channel Genes and Propensity to TdP |
|
Methods |
Pierre Maison Blanche |
RR Bin Approach for QT analyses |
|
Clinical Aspects |
Mark Haigney |
QT Variability and its Application for Drug Testing |
|
Drug Testing |
William Wheeelr |
Assessing QT Liability in Oncology Drug Development |
October 21th
|
Mechanisms |
Michael Ackerman |
Pharmacogenetics of Drug-Induced Sudden Cardiac Arrest |
|
Methods |
Antony Fossa |
ECG Restitution and its Relevance for Drug-Induced Repolarization Abnormalities |
|
Clinical Aspects |
Ihor Gussak |
Short QT Interval and Drugs |
|
Drug Testing |
Irina Salivieva |
Pacing in Drug Testing |
October 22th
|
Clinical Aspects |
Li Zhang |
Case Demonstrations in Congenital and Acquired Long QT Syndrome. Can You Make A Correct ECG Interpretation? |
|
Methods |
Stefan Kaab |
Drug-induced LQT-Syndrome: Sotalol-Experience, Heart failure, Susceptibility to drug induced LQT |
|
Methods |
Andrés Pérez Riera |
Relationship Among Amiodarone, New Class III Antiarrhytmics, Miscellaneous Agents and Acquired Long QT Syndrome |
October 23th - 31th
|
Discussion |
|
|